Trials / Sponsors / Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc.
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC) Metastatic Castration Resistant Prostate Cancer (mCRPC) | Phase 1 / Phase 2 | 2026-01-09 |
| Active Not Recruiting | AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRC Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Recurrence | Phase 1 / Phase 2 | 2024-02-26 |
| Active Not Recruiting | AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Can Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Fallopian Tube Neoplasms | Phase 1 | 2022-11-29 |